Notably, a recent meta-analysis showed that triple positivity for RF, ACPA, and anti-carbamylated protein antibodies was highly specific to patients with active RA, and patients who would go on to develop RA (122). The gene discussed is PRTN3; the disease is rheumatoid arthritis.